Company intelligence / Profile preview

Peter Ferdinandy

Budapest, Budapest, Hungaryesc365.escardio.org ↗

Ownership: Private
Development stage: Other

Overview

Provides innovative preclinical pharmacology and clinical trial management services focused on cardiovascular, metabolic, renal, and inflammatory diseases. Over two decades of experience with more than 300 development projects. Also develops new technologies for outlicensing/co-development in diagnosis and therapy of cardiometabolic diseases.[1][3][4][5]. No public data on specific clinical results as a sponsor—primarily supports clients' programs.

Founder & CEO Péter Ferdinandy recognized as a Highly Cited Researcher multiple times; company has strong scientific credentials.[3]

Therapeutic areas: Metabolic DisordersEndocrinologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeMedical device (device)Biologic (for advanced therapies)Peptides (as part of cardiovascular/metabolic research models)
Industry: Drug Discovery Services

Partnerships

None specifically disclosed. Collaborates widely with pharma/biotech/device companies via contract research engagements.[5]

Beyond the preview

Go deeper on Peter Ferdinandy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peter Ferdinandy.

Explore the full profile